Covid-19
Convalescent
Plasma

CCP stands for Covid-19 Convalescent Plasma, plasma collected from Covid-19 recovered patients.
CCP contains antibodies that could neutralize SARS-CoV-2 and thus may improve disease course in patients with SARS-CoV-2.


Learn more >

Project
description

SUPPORT-E - SUPPORTing high quality
evaluation of Covid-19 convalescent plasma
throughout Europe -
is a research project
supported by the European Commission which
brings together major European Blood
Establishments. Its aim is to support high quality

clinical and scientific evaluation of Covid-19
Convalescent Plasma (CCP), using among other things
the dedicated database created by the European Commission.
The main goal of the project is to help EU countries
in both assessing the efficacy of a new therapeutic
solution to deal with the current Coronavirus crisis and
developing new strategies to face potential future pandemics.

Learn more about Support-e >
Learn more about the CCP Database >

COVIC-19

COVIC-19 is a randomized controlled clinical trial that meant to evaluate, with the highest scientific standards, the effectiveness and safety of CCP (COVID-19 Convalescent Plasma) as early treatment in immunocompromised COVID-19 patients.


Learn more >



Objectives

I

Support High Quality
CCP donation

II

Support High Quality CCP Evaluation in clinical trials and monitored access use programmes

III

Deliver Recommendations for the collection and use of CCP in EU member states to treat Covid-19

IV

Deliver Recommendations for future outbreaks

V

Ensure EU wide adoptions of recommendations and project legacy